These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7905522)

  • 21. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
    Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
    Cochrane Database Syst Rev; 2000; 2000(2):CD002038. PubMed ID: 10796851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
    Richman DD
    Am J Med; 1990 May; 88(5B):8S-10S. PubMed ID: 2186629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zalcitabine.
    Shelton MJ; O'Donnell AM; Morse GD
    Ann Pharmacother; 1993 Apr; 27(4):480-9. PubMed ID: 8097417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex.
    Meng TC; Fischl MA; Richman DD
    Am J Med; 1990 May; 88(5B):27S-30S. PubMed ID: 2159707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ddC (zalcitabine).
    Skowron G
    Adv Exp Med Biol; 1996; 394():257-69. PubMed ID: 8815690
    [No Abstract]   [Full Text] [Related]  

  • 27. Zidovudine resistance of human immunodeficiency virus.
    Richman DD
    Rev Infect Dis; 1990; 12 Suppl 5():S507-10; discussion S510-2. PubMed ID: 2201072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current use of anti-HIV drugs in AIDS.
    Clumeck N
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():133-8. PubMed ID: 8407695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ritonavir.
    Lea AP; Faulds D
    Drugs; 1996 Oct; 52(4):541-6; discussion 547-8. PubMed ID: 8891466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleosides.
    Pizzo PA
    Am J Med; 1990 May; 88(5B):16S-19S. PubMed ID: 2159704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy: more effective control of HIV type 1?
    Johnson VA
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):907-12. PubMed ID: 7811541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antiviral activity of didanosine compared with that of other dideoxynucleoside analogs against laboratory strains and clinical isolates of human immunodeficiency virus.
    Hitchcock MJ
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S16-21. PubMed ID: 8425017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus.
    Richman DD; Meng TC; Spector SA; Fischl MA; Resnick L; Lai S
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):135-8. PubMed ID: 7905522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
    Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
    Cochrane Database Syst Rev; 2000; (3):CD002038. PubMed ID: 10908523
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.